KKJ00626
KKJ00626 is an inhibitor for Hepatitis B virus (HBV) with an IC50 of 0.12~0.23 μM. KKJ00626 inhibits the interaction between HBV core protein and the surface protein PreS region, prevents the maturation and secretion of HBV particles, and exhibits antiviral efficacy[1].
Product Specifications
CAS Number
[51646-17-4]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
HBV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
S=C1NN2C(C)=CC(C)=NC2=N1
Molecular Formula
C7H8N4S
Molecular Weight
180.23
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]Asif-Ullah M, et al., Identification of compounds that inhibit the interaction between core and surface protein of hepatitis B virus. Antiviral Res. 2006 Jun;70 (2) :85-90.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
